ZAFGEN, INC.

Company

Larimar Therapeutics, Inc.

Filed

February 13, 2015

Accession Number

0001072613-15-000136

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →